{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:54:15Z","timestamp":1791338055227,"version":"4.3.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00415-016-8263-4","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T06:33:05Z","timestamp":1473229985000},"page":"1035-1050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["Vaccines and multiple sclerosis: a systematic review"],"prefix":"10.1007","volume":"264","author":[{"given":"Mia Tops\u00f8e","family":"Mailand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette Lautrup","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"8263_CR1","first-page":"115","volume":"304","author":"F Denis","year":"2006","unstructured":"Denis F, Levy-Bruhl D (2006) Mass vaccination against hepatitis B: the French example. Curr Top Microbiol Immunol 304:115\u2013129","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"8263_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40263-015-0226-2","volume":"29","author":"EM Williamson","year":"2015","unstructured":"Williamson EM, Berger JR (2015) Infection risk in patients on multiple sclerosis therapeutics. CNS Drugs 29(3):229\u2013244","journal-title":"CNS Drugs"},{"issue":"5","key":"8263_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-2893.2003.00423.x","volume":"10","author":"V Demicheli","year":"2003","unstructured":"Demicheli V et al (2003) Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review. J Viral Hepat 10(5):343\u2013344","journal-title":"J Viral Hepat"},{"issue":"4","key":"8263_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1586\/14760584.1.4.461","volume":"1","author":"F DeStefano","year":"2002","unstructured":"DeStefano F, Verstraeten T, Chen RT (2002) Hepatitis B vaccine and risk of multiple sclerosis. Expert Rev Vaccines 1(4):461\u2013466","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"8263_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00415-011-5984-2","volume":"258","author":"MF Farez","year":"2011","unstructured":"Farez MF, Correale J (2011) Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol 258(7):1197\u20131206","journal-title":"J Neurol"},{"issue":"2","key":"8263_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s100720170014","volume":"22","author":"O Gout","year":"2001","unstructured":"Gout O (2001) Vaccinations and multiple sclerosis. Neurol Sci 22(2):151\u2013154","journal-title":"Neurol Sci"},{"issue":"4","key":"8263_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2165\/00002018-200124040-00002","volume":"24","author":"T Jefferson","year":"2001","unstructured":"Jefferson T, Heijbel H (2001) Demyelinating disease and hepatitis B vaccination: is there a link? Drug Saf 24(4):249\u2013254","journal-title":"Drug Saf"},{"issue":"3","key":"8263_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrneurol.2012.8","volume":"8","author":"M Loebermann","year":"2011","unstructured":"Loebermann M et al (2011) Vaccination against infection in patients with multiple sclerosis. Nat Rev Neurol 8(3):143\u2013151","journal-title":"Nat Rev Neurol"},{"issue":"4 Suppl 2","key":"8263_CR9","doi-asserted-by":"publisher","first-page":"S853","DOI":"10.1007\/s100720070025","volume":"21","author":"E Merelli","year":"2000","unstructured":"Merelli E, Casoni F (2000) Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B. Neurol Sci 21(4 Suppl 2):S853\u2013S856","journal-title":"Neurol Sci"},{"issue":"1","key":"8263_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1345\/aph.1A096","volume":"36","author":"EJ Sievers","year":"2002","unstructured":"Sievers EJ, Heyneman CA (2002) Relationship between vaccinations and multiple sclerosis. Ann Pharmacother 36(1):160\u2013162","journal-title":"Ann Pharmacother"},{"issue":"5","key":"8263_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJM200102013440502","volume":"344","author":"A Ascherio","year":"2001","unstructured":"Ascherio A et al (2001) Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344(5):327\u2013332","journal-title":"N Engl J Med"},{"issue":"4","key":"8263_CR12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/archneur.60.4.504","volume":"60","author":"F DeStefano","year":"2003","unstructured":"DeStefano F et al (2003) Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 60(4):504\u2013509","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"8263_CR13","first-page":"31","volume":"23","author":"MM Eftekharian","year":"2014","unstructured":"Eftekharian MM et al (2014) Multiple sclerosis and immunological-related risk factors: results from a case-control study. Hum Antibodies 23(1\u20132):31\u201336","journal-title":"Hum Antibodies"},{"issue":"4","key":"8263_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/08916930500144484","volume":"38","author":"DA Geier","year":"2005","unstructured":"Geier DA, Geier MR (2005) A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38(4):295\u2013301","journal-title":"Autoimmunity"},{"issue":"5","key":"8263_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1212\/01.WNL.0000138433.61870.82","volume":"63","author":"MA Hernan","year":"2004","unstructured":"Hernan MA et al (2004) Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 63(5):838\u2013842","journal-title":"Neurology"},{"issue":"31","key":"8263_CR16","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1016\/j.vaccine.2007.05.032","volume":"25","author":"MN Hocine","year":"2007","unstructured":"Hocine MN et al (2007) Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method. Vaccine 25(31):5938\u20135943","journal-title":"Vaccine"},{"issue":"12","key":"8263_CR17","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","volume":"71","author":"A Langer-Gould","year":"2014","unstructured":"Langer-Gould A et al (2014) Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol 71(12):1506\u20131513","journal-title":"JAMA Neurol"},{"issue":"Pt 4","key":"8263_CR18","first-page":"1105","volume":"130","author":"Y Mikaeloff","year":"2007","unstructured":"Mikaeloff Y et al (2007) Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 130(Pt 4):1105\u20131110","journal-title":"Brain"},{"issue":"12","key":"8263_CR19","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/archpedi.161.12.1176","volume":"161","author":"Y Mikaeloff","year":"2007","unstructured":"Mikaeloff Y et al (2007) Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med 161(12):1176\u20131182","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"10","key":"8263_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1212\/01.wnl.0000335762.42177.07","volume":"72","author":"Y Mikaeloff","year":"2009","unstructured":"Mikaeloff Y et al (2009) Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 72(10):873\u2013880","journal-title":"Neurology"},{"issue":"3","key":"8263_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1399-0039.2006.00653.x","volume":"68","author":"S Ozakbas","year":"2006","unstructured":"Ozakbas S et al (2006) Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes. Tissue Antigens 68(3):235\u2013238","journal-title":"Tissue Antigens"},{"issue":"4","key":"8263_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000201564","volume":"32","author":"SV Ramagopalan","year":"2009","unstructured":"Ramagopalan SV et al (2009) Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology 32(4):257\u2013262","journal-title":"Neuroepidemiology"},{"issue":"9203","key":"8263_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(99)02991-8","volume":"355","author":"AD Sadovnick","year":"2000","unstructured":"Sadovnick AD, Scheifele DW (2000) School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 355(9203):549\u2013550","journal-title":"Lancet"},{"issue":"4","key":"8263_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000059520","volume":"21","author":"E Touze","year":"2002","unstructured":"Touze E et al (2002) Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology 21(4):180\u2013186","journal-title":"Neuroepidemiology"},{"issue":"9","key":"8263_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/12376","volume":"5","author":"F Zipp","year":"1999","unstructured":"Zipp F, Weil JG, Einhaupl KM (1999) No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 5(9):964\u2013965","journal-title":"Nat Med"},{"issue":"5","key":"8263_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJM200102013440501","volume":"344","author":"C Confavreux","year":"2001","unstructured":"Confavreux C et al (2001) Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med 344(5):319\u2013326","journal-title":"N Engl J Med"},{"issue":"2","key":"8263_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","volume":"271","author":"C Chao","year":"2012","unstructured":"Chao C et al (2012) Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med 271(2):193\u2013203","journal-title":"J Intern Med"},{"issue":"4","key":"8263_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/joim.12155","volume":"275","author":"L Grimaldi-Bensouda","year":"2014","unstructured":"Grimaldi-Bensouda L et al (2014) Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med 275(4):398\u2013408","journal-title":"J Intern Med"},{"issue":"8","key":"8263_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10654-013-9830-y","volume":"28","author":"P Pellegrino","year":"2013","unstructured":"Pellegrino P et al (2013) No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus. Eur J Epidemiol 28(8):705\u2013707","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"8263_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jama.2014.16946","volume":"313","author":"NM Scheller","year":"2015","unstructured":"Scheller NM et al (2015) Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. JAMA 313(1):54\u201361","journal-title":"JAMA"},{"issue":"2","key":"8263_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1212\/WNL.18.2.109","volume":"18","author":"M Alter","year":"1968","unstructured":"Alter M, Speer J (1968) Clinical evaluation of possible etiologic factors in multiple sclerosis. Neurology 18(2):109\u2013116","journal-title":"Neurology"},{"key":"8263_CR32","doi-asserted-by":"publisher","first-page":"d5956","DOI":"10.1136\/bmj.d5956","volume":"343","author":"C Bardage","year":"2011","unstructured":"Bardage C et al (2011) Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. Bmj 343:d5956","journal-title":"Bmj"},{"issue":"4","key":"8263_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s10072-003-0147-6","volume":"24","author":"M Zorzon","year":"2003","unstructured":"Zorzon M et al (2003) Risk factors of multiple sclerosis: a case-control study. Neurol Sci 24(4):242\u2013247","journal-title":"Neurol Sci"},{"issue":"1\u20132","key":"8263_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jns.2011.10.013","volume":"314","author":"E Auriel","year":"2012","unstructured":"Auriel E et al (2012) Seasonal and H1N1v influenza vaccines in MS: safety and compliance. J Neurol Sci 314(1\u20132):102\u2013103","journal-title":"J Neurol Sci"},{"issue":"4","key":"8263_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1001\/archneur.1978.00500280060012","volume":"35","author":"CR Bamford","year":"1978","unstructured":"Bamford CR, Sibley WA, Laguna JF (1978) Swine influenza vaccination in patients with multiple sclerosis. Arch Neurol 35(4):242\u2013243","journal-title":"Arch Neurol"},{"issue":"1","key":"8263_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0022-510X(98)00139-7","volume":"159","author":"J De Keyser","year":"1998","unstructured":"De Keyser J, Zwanikken C, Boon M (1998) Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci 159(1):51\u201353","journal-title":"J Neurol Sci"},{"issue":"2","key":"8263_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1352458511417253","volume":"18","author":"MF Farez","year":"2012","unstructured":"Farez MF et al (2012) H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study. Mult Scler 18(2):254\u2013256","journal-title":"Mult Scler"},{"issue":"8","key":"8263_CR38","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00415-011-5944-x","volume":"258","author":"N McNicholas","year":"2011","unstructured":"McNicholas N, Chataway J (2011) Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination. J Neurol 258(8):1545\u20131547","journal-title":"J Neurol"},{"issue":"5","key":"8263_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000117358","volume":"30","author":"B Michielsens","year":"1990","unstructured":"Michielsens B et al (1990) Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination. Eur Neurol 30(5):258\u2013259","journal-title":"Eur Neurol"},{"issue":"2","key":"8263_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/WNL.48.2.312","volume":"48","author":"AE Miller","year":"1997","unstructured":"Miller AE et al (1997) A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 48(2):312\u2013314","journal-title":"Neurology"},{"issue":"4","key":"8263_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/135245859700300405","volume":"3","author":"F Mokhtarian","year":"1997","unstructured":"Mokhtarian F et al (1997) Influenza virus vaccination of patients with multiple sclerosis. Mult Scler 3(4):243\u2013247","journal-title":"Mult Scler"},{"issue":"7","key":"8263_CR42","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1212\/WNL.56.7.938","volume":"56","author":"NF Moriabadi","year":"2001","unstructured":"Moriabadi NF et al (2001) Influenza vaccination in MS: absence of T-cell response against white matter proteins. Neurology 56(7):938\u2013943","journal-title":"Neurology"},{"issue":"Suppl","key":"8263_CR43","doi-asserted-by":"publisher","first-page":"S546","DOI":"10.1093\/infdis\/136.Supplement_3.S546","volume":"136","author":"LW Myers","year":"1977","unstructured":"Myers LW et al (1977) Swine influenza virus vaccination in patients with multiple sclerosis. J Infect Dis 136(Suppl):S546\u2013S554","journal-title":"J Infect Dis"},{"issue":"3","key":"8263_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF00936886","volume":"242","author":"M Salvetti","year":"1995","unstructured":"Salvetti M et al (1995) Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination. J Neurol 242(3):143\u2013146","journal-title":"J Neurol"},{"issue":"17","key":"8263_CR45","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.1976.03270180041018","volume":"236","author":"WA Sibley","year":"1976","unstructured":"Sibley WA, Bamford CR, Laguna JF (1976) Influenza vaccination in patients with multiple sclerosis. JAMA 236(17):1965\u20131966","journal-title":"JAMA"},{"key":"8263_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1749-6632.1965.tb20229.x","volume":"122","author":"WA Sibley","year":"1965","unstructured":"Sibley WA, Foley JM (1965) Infection and immunization in multiple sclerosis. Ann N Y Acad Sci 122:457\u2013466","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"8263_CR47","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-009-9367-2","volume":"24","author":"C Ahlgren","year":"2009","unstructured":"Ahlgren C et al (2009) A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur J Epidemiol 24(9):541\u2013552","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"8263_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1600-0404.1997.tb00075.x","volume":"95","author":"S Bansil","year":"1997","unstructured":"Bansil S et al (1997) Multiple sclerosis in India: a case-control study of environmental exposures. Acta Neurol Scand 95(2):90\u201395","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"8263_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-0404.1997.tb00258.x","volume":"96","author":"JF Kurtzke","year":"1997","unstructured":"Kurtzke JF et al (1997) Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls. Acta Neurol Scand 96(3):149\u2013157","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"8263_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000080094","volume":"23","author":"T Pekmezovic","year":"2004","unstructured":"Pekmezovic T, Jarebinski M, Drulovic J (2004) Childhood infections as risk factors for multiple sclerosis: Belgrade case-control study. Neuroepidemiology 23(6):285\u2013288","journal-title":"Neuroepidemiology"},{"issue":"6","key":"8263_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1600-0404.1996.tb00051.x","volume":"94","author":"N Zilber","year":"1996","unstructured":"Zilber N, Kahana E (1996) Risk factors for multiple sclerosis: a case-control study in Israel. Acta Neurol Scand 94(6):395\u2013403","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"8263_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-0404.2008.01131.x","volume":"119","author":"C Ahlgren","year":"2009","unstructured":"Ahlgren C et al (2009) Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurol Scand 119(5):313\u2013320","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"8263_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1600-0404.1981.tb00756.x","volume":"63","author":"E Andersen","year":"1981","unstructured":"Andersen E, Isager H, Hyllested K (1981) Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy. Acta Neurol Scand 63(2):131\u2013135","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"8263_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000110369","volume":"13","author":"I Casetta","year":"1994","unstructured":"Casetta I et al (1994) Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 13(3):120\u2013128","journal-title":"Neuroepidemiology"},{"issue":"Pt 2","key":"8263_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/brain\/109.2.325","volume":"109","author":"DA Compston","year":"1986","unstructured":"Compston DA et al (1986) Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 109(Pt 2):325\u2013344","journal-title":"Brain"},{"issue":"1","key":"8263_CR56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1600-0404.1989.tb03841.x","volume":"80","author":"C Berr","year":"1989","unstructured":"Berr C et al (1989) Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrenees, France. Acta Neurol Scand 80(1):46\u201350","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"8263_CR57","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1212\/WNL.53.7.1588","volume":"53","author":"G Ristori","year":"1999","unstructured":"Ristori G et al (1999) Use of Bacille Calmette\u2013Guerin (BCG) in multiple sclerosis. Neurology 53(7):1588\u20131589","journal-title":"Neurology"},{"issue":"10","key":"8263_CR58","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/archneurol.2011.131","volume":"68","author":"MF Farez","year":"2011","unstructured":"Farez MF, Correale J (2011) Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis. Arch Neurol 68(10):1267\u20131271","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"8263_CR59","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/S0264-410X(02)00815-0","volume":"21","author":"U Baumhackl","year":"2003","unstructured":"Baumhackl U et al (2003) A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis. Vaccine 21(Suppl 1):S56\u2013S61","journal-title":"Vaccine"},{"issue":"4","key":"8263_CR60","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0264-410X(91)90104-E","volume":"9","author":"U Quast","year":"1991","unstructured":"Quast U, Herder C, Zwisler O (1991) Vaccination of patients with encephalomyelitis disseminata. Vaccine 9(4):228\u2013230","journal-title":"Vaccine"},{"issue":"1","key":"8263_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","volume":"82","author":"G Ristori","year":"2014","unstructured":"Ristori G et al (2014) Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS. Neurology 82(1):41\u201348","journal-title":"Neurology"},{"issue":"1","key":"8263_CR62","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/archneurol.2011.1519","volume":"69","author":"V Pool","year":"2012","unstructured":"Pool V, Gordon DM, Decker M (2012) Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination. Arch Neurol 69(1):144 (author reply 144-5)","journal-title":"Arch Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-016-8263-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T14:15:33Z","timestamp":1684851333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-016-8263-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["8263"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8263-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]},"assertion":[{"value":"20 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}